An Open-label, Single-sequence Study to Investigate the Effects of BMS-986165 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil (MMF) in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2018
At a glance
- Drugs BMS 986165 (Primary) ; Mycophenolate mofetil
- Indications Autoimmune disorders; Crohn's disease; Inflammatory bowel diseases; Plaque psoriasis; Psoriasis; Psoriatic arthritis; Systemic lupus erythematosus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 27 Nov 2018 Status changed from active, no longer recruiting to completed.
- 05 Nov 2018 Planned End Date changed from 2 Oct 2018 to 6 Nov 2018.
- 05 Nov 2018 Status changed from recruiting to active, no longer recruiting.